- Bristol-Myers Squibb shares surged after AstraZeneca explored an acquisition of the drugmaker; AstraZeneca shares fell.
- The report places both companies at the center of a potential large-cap pharmaceutical M&A transaction.
Quotes
“Bristol-Myers Squibb (SQB) shares are surging on news AstraZeneca (AZN), whose shares are lower, is exploring an acquisition of Bristol-Myers Squibb.”